v3.25.2
Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
Total
Previously Reported
Revision of Prior Period, Adjustment
Convertible Notes Payable
Bridge Loan
Private Placement
Private Placement
Warrant
Settle Transaction Expenses
Potential shares from Pre-Paid Advance
Potential shares from Cable Car Note
Non-Redemption Extension Agreement
Early Investor Consideration
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Common Stock
Convertible Notes Payable
Common Stock
Bridge Loan
Common Stock
Private Placement
Common Stock
Settle Transaction Expenses
Common Stock
Potential shares from Pre-Paid Advance
Common Stock
Potential shares from Cable Car Note
Common Stock
Non-Redemption Extension Agreement
Common Stock
Early Investor Consideration
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Convertible Notes Payable
Additional Paid-in Capital
Bridge Loan
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Private Placement
Warrant
Additional Paid-in Capital
Settle Transaction Expenses
Additional Paid-in Capital
Potential shares from Pre-Paid Advance
Additional Paid-in Capital
Potential shares from Cable Car Note
Additional Paid-in Capital
Non-Redemption Extension Agreement
Additional Paid-in Capital
Early Investor Consideration
Accumulated Deficit
Accumulated Deficit
Previously Reported
Beginning balance (in shares) at Dec. 31, 2023                         9,575,925 [1] 27,941,290 (18,365,365)                                            
Beginning balance at Dec. 31, 2023 $ (5,312,079) [1] $ (5,312,079) $ 0                   $ 958 [1] $ 27,941 $ (26,983)                 $ 12,457,108 [1] $ 12,430,125 $ 26,983                   $ (17,770,145) [1] $ (17,770,145)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                          
Merger recapitalization (in shares)                         7,898,954                                                
Merger recapitalization (12,939,165)                       $ 790                     (12,939,955)                          
Issuance of common stock pursuant to a subscription agreement (in shares)                         200,000                                                
Issuance of common stock pursuant to a subscription agreement 706,000                       $ 20                     705,980                          
Conversion of a note convertible securities (in shares)                               359,266 100,000                                        
Conversion of a note convertible securities       $ 3,233,388 $ 200,000                     $ 36 $ 10                   $ 3,233,352 $ 199,990                  
Net exercise of warrants (in shares)                         5,594                                                
Net exercise of warrants 0                       $ 1                     (1)                          
Issuance of common stock (in shares)                                     1,544,200 1,000,000 180,000 427,477 150,000                            
Issuance of common stock               $ 5,439,857 $ 1,866,284 $ 446,333 $ 1,508,993 $ 529,500             $ 154 $ 100 $ 18 $ 42 $ 15               $ 5,439,703 $ 1,866,184 $ 446,315 $ 1,508,951 $ 529,485    
Stock-based compensation 38,984                                             38,984                          
Deemed dividend related to modification of equity classified warrants 0                                             5,185,502                       (5,185,502)  
Net loss (1,877,464) $ (5,547,464)                                                                   (1,877,464)  
Ending balance (in shares) at Jun. 30, 2024                         21,441,416                                                
Ending balance at Jun. 30, 2024 (6,159,369)                       $ 2,144                     18,671,598                       (24,833,111)  
Beginning balance (in shares) at Mar. 31, 2024                         21,437,216                                                
Beginning balance at Mar. 31, 2024 (4,914,150)                       $ 2,144                     13,482,441                       (18,398,735)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                          
Issuance of common stock (in shares)                                     4,200                                    
Issuance of common stock               $ 3,655                                             $ 3,655            
Deemed dividend related to modification of equity classified warrants 0                                             5,185,502                       (5,185,502)  
Net loss (1,248,874)                                                                     (1,248,874)  
Ending balance (in shares) at Jun. 30, 2024                         21,441,416                                                
Ending balance at Jun. 30, 2024 $ (6,159,369)                       $ 2,144                     18,671,598                       (24,833,111)  
Beginning balance (in shares) at Dec. 31, 2024 26,768,210                       26,768,210                                                
Beginning balance at Dec. 31, 2024 $ (9,538,284)                       $ 2,676                     22,399,567                       (31,940,527)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                          
Issuance of common stock (in shares)                         885,000         990,268                                      
Issuance of common stock 366,210         $ 298,730 $ 380,511           $ 89         $ 99           366,121         $ 298,631 $ 380,511              
Reclassification of warrant liability upon warrant modification 22,986,128                                             22,986,128                          
Stock-based compensation 319,926                                             319,926                          
Net loss $ (15,137,515)                                                                     (15,137,515)  
Ending balance (in shares) at Jun. 30, 2025 28,643,478                       28,643,478                                                
Ending balance at Jun. 30, 2025 $ (324,294)                       $ 2,864                     46,750,884                       (47,078,042)  
Beginning balance (in shares) at Mar. 31, 2025                         27,653,210                                                
Beginning balance at Mar. 31, 2025 (20,207,358)                       $ 2,765                     22,866,404                       (43,076,527)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                          
Issuance of common stock (in shares)                                   990,268                                      
Issuance of common stock           $ 298,730 $ 380,511                     $ 99                     $ 298,631 $ 380,511              
Reclassification of warrant liability upon warrant modification 22,986,128                                             22,986,128                          
Stock-based compensation 219,210                                             219,210                          
Net loss $ (4,001,515)                                                                     (4,001,515)  
Ending balance (in shares) at Jun. 30, 2025 28,643,478                       28,643,478                                                
Ending balance at Jun. 30, 2025 $ (324,294)                       $ 2,864                     $ 46,750,884                       $ (47,078,042)  
[1]
(1) Amounts as of December 31, 2023 and before that date differ from those in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting or the Business Combination (as defined in the Notes to Condensed Consolidated Financial Statements).